Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: FDA considers autonomous and remote robots, adds flexibility to emergency diagnostic testing, and proposes 510(k)s for more companion diagnostics; medtech and the midterms; CMS delays remote monitoring payment restrictions, finalizes pass-throughs, and adds DME latitude; EU adopts updated standards and makes a pact with Singapore; and more global policy updates.
In this month's news, FDA issues 510(k) clearance for a series of AI imaging technologies, EQT buys Qiagen for upwards of $12 billion, Labcorp's acquisition spree, and more.
Recor Medical is expanding access to its ultrasound renal denervation technology with the help of Medicare coverage, professional guidelines, and clinical results supporting renal denervation for the treatment of drug-resistant hypertension. Excerpted from our recent feature “Renal Denervation Winds Shift in Recor’s Favor.”